Log in
Enquire now
‌

SignaCor

SignaCor is a clinical-stage biotech platform exploring therapeutics for cardiac disorders, specifically hypertrophic cardiomyopathy

OverviewStructured DataIssuesContributors

Contents

signacor.co.uk
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Health technology
Health technology
CEO
‌
Chris Watson
Founder
‌
Chris Watson
Number of Employees (Ranges)
1 – 10
Email Address
info@signacor.co.uk
Investors
ZINC
ZINC
Founded Date
2024
Total Funding Amount (USD)
330,000
Latest Funding Round Date
March 9, 2026
Latest Funding Type
Seed
Seed
COO
‌
Darach Neeson
Country
United Kingdom
United Kingdom
Headquarters
Belfast
Belfast

Other attributes

Latest Funding Round Amount (USD)
330,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like SignaCor

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.